Role of dietary polyphenols and inflammatory processes on disease progression mediated by the gut microbiota

Rejuvenation Research

Volumn 16, Issue 5, 2013, Pages 435-437

  Alfredo Martinez J ^a,b,c   Etxeberría, Usune ^a   Galar, Alicia ^d   Milagro, Fermín I ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; OMEGA 3 FATTY ACID; POLYPHENOL; PROTEIN; TRACE ELEMENT; TRANSCRIPTION FACTOR FOXP3; TRIMETHYLAMINE OXIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA; METABOLISM; MICROBIOME; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; CARDIOVASCULAR DISEASES; DIET; HUMANS; MICROBIOTA;

EID: 84886010729     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2013.1481     Document Type: Article

References (15)

1. Mendelsohn AR, Larrick J. Dietary modification of the microbiome affects risk for cardiovascular disease. Rejuvenation Res 2013;16:241-244.
2. Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev 2012;70:S10-S13.
3. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J; MetaHIT Consortium, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Mérieux A, Melo Minardi R, M'rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P. Enterotypes of the human gut microbiome. Nature 2011;473:174-180.
4. Lozupone C.A, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012;489:220-230.
5. Etxeberría U, Fernández-Quintela A, Milagro FI, Aguirre L, Martínez JA, Portillo MP. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem (in press).
6. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368:1575-1584.
7. García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm Res 2009;58:537-552.
8. Lisko I, Tiainen K, Stenholm S, Luukkaala T, Hurme M, Lehtima ̈ki T, Hervonen A, Jylhä M. Inflammation, adiposity, and mortality in the oldest old. Rejuvenation Res 2012;15:445-452.
9. Moreira APB, Alfenas RC. The influence of endotoxemia on the molecular mechanisms of insulin resistance. Nutr Hosp 2012;27:382-390.
10. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013;498:99-103.
11. Marzulli G, Magrone T, Kawaguchi K, Kumazawa Y, Jirillo E. Fermented grapemarc (FGM): Immunomodulating properties and its potential exploitation in the treatment of neurodegenerative diseases. Curr Pharm Des 2012;18:43-50.
12. Cumaoǧlu A, Ari N, Kartal M, Karasu Cx. Polyphenolic extracts from Olea europea L. protect against cytokine-induced β-cell damage through maintenance of redox homeostasis. Rejuvenation Res 2011;14:325-334.
13. Zhao L. The gut microbiota and obesity: From correlation to causality. Nat Rev 2013;11:639-647.
14. Kang J. Gut microbiota and personalized nutrition, J Nutrigenet Nutrigenomics 2013;6:I-II.
15. Zhavoronkov A. From personalized medicine to personalized science: uniting science and medicine for patientdriven, goal-oriented research. Rejuvenation Res 2013; Jul 26 [Epub ahead of print]